McKesson

Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.

The coding requirements will be a particularly complicated aspect of implementing the new law which aims to move diagnostic pricing to a market-based system.

NEW YORK (GenomeWeb News) – Atossa Genetics today said that McKesson Medical-Surgical will distribute and sell the firm's MASCT device and patient collection kits.

Theranostics Health this week announced the June launch of its first commercial test, a 14-protein assay for profiling activation of the HER signaling network.

In a move that surprised many stakeholders in the molecular diagnostics industry, the American Medical Association and healthcare information technology firm McKesson last week announced that they are working together to harmonize their respective coding systems for molecular tes

NEW YORK (GenomeWeb News) – The American Medical Association and McKesson announced a licensing deal today to create a reference product for identifying and tracking molecular diagnostic tests.

This article has been updated to include comments from Palmetto Medical Director Elaine Jeter. Originally published Jan. 26.

This article has been updated to clarify information about NIH's Genetic Testing Registry.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.